Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
Youyi Fong(Fred Hutch Cancer Center), Cecilia Losada(Emory University), Lilly Cheng Immergluck, Emmanuel B. Walter(Duke University), Siham Mahgoub(Howard University Hospital), Jinjian Mu(Emmes (United States)), David Diemert(George Washington University), Christine M. Posavad(Fred Hutch Cancer Center), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Aimee Desrosiers, Seema Nayak(Unknown), Paul C. Roberts(National Institutes of Health), Susan J. Little(University of California San Diego), Craig A. Magaret(Fred Hutch Cancer Center), Mamodikoe Makhene(National Institutes of Health), Nadine Rouphael(Emory University), Rachel M. Presti(Johns Hopkins University), Jonathan Fintzi(National Institutes of Health), Jennifer A. Whitaker(Baylor College of Medicine), Patricia Winokur(University of Iowa), Richard Rupp(The University of Texas Medical Branch at Galveston), Dahlene N. Fusco(Tulane University), Dean Follmann(National Institute of Allergy and Infectious Diseases), Angelica C Kottkamp(New York University), Chenchen Yu(Fred Hutch Cancer Center), Mat Makowski(National Institutes of Health), Bhavesh Borate(Fred Hutch Cancer Center), Elissa Malkin(George Washington University), Anne F. Luetkemeyer(University of California, San Francisco), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ann R. Falsey(University of Rochester), Lindsey R. Baden(Brigham and Women's Hospital), Bo Zhang, Jing Wang(Anhui Medical University), Tara M Babu(Seattle Pacific University), Shiyu Chen(Southern Medical University), Lauren Dang(National Institutes of Health), Angela R Branche(University of Rochester), Cindy Molitor(Fred Hutch Cancer Center)
Cited by 3
Related Papers
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
|New England Journal of Medicine|2005|2.2k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k